Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceKari Fischer, Dingcheng Gao, Anna Durrans et al.|Nature|2015Cited by 1.8k
Connecting copper and cancer: from transition metal signalling to metalloplasiaEva J. Ge, Christopher J. Chang, Ashley I. Bush et al.|Nature reviews. Cancer|2021Cited by 1.3k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyJavier Cortés, Chris Twelves, Seth Seegobin et al.|The Lancet|2011Cited by 1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast CancerAditya Bardia, Kevin Kalinsky, Ingrid A. Mayer et al.|New England Journal of Medicine|2019Cited by 846
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane TreatmentE. Donnall Thomas, Henri Roché, Henry Gómez et al.|Journal of Clinical Oncology|2007Cited by 483